SURGE Therapeutics

Cambridge, United States

SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed.

$32.0M raised

Jul 2023

Series B

Biotechnology Health Care Life Science

Top Investors

Alumni VenturesKhosla Ventures8VCPitango VCKdT Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about SURGE Therapeutics

How much funding has SURGE Therapeutics raised?

SURGE Therapeutics has raised $32.0M in total funding. The most recent round was Series B. The last funding was announced in July 2023.

Who are SURGE Therapeutics's investors?

SURGE Therapeutics's investors include Alumni Ventures, Khosla Ventures, 8VC, Pitango VC, KdT Ventures.

Where is SURGE Therapeutics headquartered?

SURGE Therapeutics is headquartered in Cambridge, United States.

What does SURGE Therapeutics do?

SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed.

What stage is SURGE Therapeutics at?

SURGE Therapeutics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 19, 2023.

MLA

"SURGE Therapeutics — Funding & Investors." VCBacked, July 19, 2023, https://www.vcbacked.co/company/surge-therapeutics. Accessed June 3, 2026.

APA

VCBacked. (2023). SURGE Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/surge-therapeutics

Wikipedia (cite web)

{{cite web |title=SURGE Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/surge-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 19, 2023.

Similar Companies in Biotechnology